The Bill & Melinda Gates Foundation Tax Return Was E-Filed with The

Total Page:16

File Type:pdf, Size:1020Kb

Load more

The Bill & Melinda Gates Foundation tax return was e-filed with the Internal Revenue Service. The tax return and accompanying attachments posted on our website are presented as a view of the electronically filed data.

Please note for ease of navigating the tax return we have bookmarked the various sections of the return.

efile GRAPHIC print - DO NOT PROCESS

ORIGINAL DATA -

EIN: 562618866

OMB No. 1545-0052

Return of Private Foundation

or Section 4947(a)(1) Nonexempt Charitable Trust
Treated as a Private Foundation

Form

990-PF

2007

Note: The foundation may be able to use a copy of this return to satisfy state reporting requirements.

Department of the Treasury Internal Revenue Service

For calendar year 2007 , or tax year beginning 01-01-2007 and ending 12-31-2007

G

  • Check all that apply:
  • Initial return
  • Final return
  • Amended return
  • Address change
  • Name change

A Employer identification number

Name of foundation

Use the IRS label.

BILL & MELINDA GATES FOUNDATION
56-2618866

Otherwise, print or type.

B Telephone number (see page 10 of the instructions)
Room/

suite
Number and street (or P.O. box number if mail is not delivered to street address)
1551 EASTLAKE AVENUE EAST
(206) 709-3100

See Specific Instructions.

C If exemption application is pending, check here
City or town, state, and ZIP code

SEATTLE, WA 98102
D 1. Foreign organizations, check here .

2. Foreign organizations meeting the 85% test, check here and attach computation

  • H Check type of organization:
  • Section 501(c)(3) exempt private foundation

  • Section 4947(a)(1) nonexempt charitable trust
  • Other taxable private foundation

Cash Accrual

EF

If private foundation status was terminated under section 507(b)(1)(A), check here

J Accounting method:

Other (specify)

(Part I, column (d) must be on cash basis.)

I Fair market value of all assets at end

of year (from Part II, col. (c),

If the foundation is in a 60-month termination under section 507(b)(1)(B), check here

line 16)

$

38,837,820,007

(d) Disbursements

for charitable purposes

Part I

Analysis of Revenue and Expenses (The total

of amounts in columns (b), (c), and (d) may not necessarily equal the amounts in column (a) (see page 11 of the instructions).)

(a) Revenue and

expenses per books

  • (b) Net investment
  • (c) Adjusted net

  • income
  • income

(cash basis only)

2,327,493,095

12

Contributions, gifts, grants, etc., received (attach schedule) Check if the foundation is not required to attach Sch. B

794,161 438,307
-7,779
794,161 438,307
00

Interest on savings and temporary cash investments

3

Dividends and interest from securities Gross rents Net rental income or (loss)

..
..
..
..
..
..
4

  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .

5a

b

-120,818

Net gain or (loss) from sale of assets not on line 10

Gross sales price for all assets on line 6a

6a b

0

Capital gain net income (from Part IV, line 2)

...
...
...
7

Net short-term capital gain Income modifications

..
..
..
..
..
..
8

  • .
  • .

9

10a b

Gross sales less returns and allowances

Less: Cost of goods sold

  • .
  • .
  • .
  • .

Gross profit or (loss) (attach schedule)

..
..
..
..
..c

  • 1,500,438
  • 1,409,069

2,641,537
00

Other income (attach schedule)

..
..
11

2,330,218,222
2,911,479
51,717,783 16,972,774
2,059,208
248,600

  • Total. Add lines 1 through 11
  • .
  • .
  • .
  • .
  • .
  • .

12

13 14 15 16a b

2,900,189
49,483,466 16,472,005
2,177,743
248,600

Compensation of officers, directors, trustees, etc. Other employee salaries and wages Pension plans, employee benefits

....
....
....
....
....
....
...

00
00

Legal fees (attach schedule)

  • .
  • .

Accounting fees (attach schedule)

  • 124,146,643
  • 0
  • 0

0
115,103,091
228,294

Other professional fees (attach schedule) Interest

..
..
..
..c

  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .

17

18

  • 321,354
  • 74,156

Taxes (attach schedule) (see page 14 of the instructions)

3,662,573

Depreciation (attach schedule) and depletion

  • .
  • .
  • .

19

13,317,075 23,804,733
584,873

  • 559,125
  • 12,237,820

23,694,932
1,020,216
23,198,644

Occupancy Travel, conferences, and meetings Printing and publications Other expenses (attach schedule)

  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .

...
....
....
....
....
....
....
20 21 22 23

  • .
  • .
  • .

  • 23,919,204
  • 0
  • 0

FOR PUBLIC DISCLOSURE

  • Total operating and administrative expenses.
  • 24

263,666,299
3,048,299,105 3,311,965,404
633,281 633,281
00
246,765,000
2,011,456,496 2,258,221,496

Add lines 13 through 23

  • .
  • .
  • .

.
..
..
..
..
..
..
..

Contributions, gifts, grants paid

25 26

Total expenses and disbursements. Add lines 24 and 25

27 a

Subtract line 26 from line 12:

-981,747,182

Excess of revenue over expenses and disbursements

2,008,256

Net investment income (if negative, enter -0-) b

c

0

  • Adjusted net income (if negative, enter -0-)
  • .
  • .
  • .

For Privacy Act and Paperwork Reduction Act Notice, see the instructions.

Cat. No. 11289X

Form 990-PF (2007)

FOR PUBLIC DISCLOSURE

Form 990-PF (2007)

Page 2

  • Beginning of year
  • End of year

Attached schedules and amounts in the description column

should be for end-of-year amounts only. (See instructions.)

Balance Sheets

Part II

  • (a) Book Value
  • (b) Book Value

427,483

(c) Fair Market Value

  • 100
  • 427,483

Cash—non-interest-bearing .

  • .
  • .
  • .
  • .
  • .

.
..
..
..
..
..
..
..
..
..
123

5,524,412
0

  • 9,517,454
  • 9,517,454

249,840

Savings and temporary cash investments

249,840

Accounts receivable

0
249,840

Less: allowance for doubtful accounts Pledges receivable

4

Less: allowance for doubtful accounts Grants receivable

  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .

.
..
..
..
..
56

Receivables due from officers, directors, trustees, and other disqualified persons (attach schedule) (see page 16 of the

  • instructions).
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .

Other notes and loans receivable (attach schedule) Less: allowance for doubtful accounts

7

Inventories for sale or use

  • .
  • .
  • .
  • .
  • .

.
..
..
..
..
..
..
..
..
..
..
89

  • 327,042
  • 1,589,790
  • 1,589,790

Prepaid expenses and deferred charges Investments—U.S. and state government obligations (attach schedule)

10a b

Investments—corporate stock (attach schedule) Investments—corporate bonds (attach schedule)

..
..
..
..
..
..
..
..c

43,634,081
0

Investments—land, buildings, and equipment: basis Less: accumulated depreciation (attach schedule)

11

  • 11,157,821
  • 43,634,081
  • 43,634,081

Investments—mortgage loans

  • .
  • .
  • .
  • .

.
..
..
..
..
..
..
..
..
..
..
12 13 14

  • 29,564,176,183
  • 38,652,975,969
  • 38,652,975,969

Investments—other (attach schedule) Land, buildings, and equipment: basis

140,320,775

  • 41,406,979
  • 43,349,460

30,005,792
98,913,796 30,511,594
98,913,796 30,511,594

Less: accumulated depreciation (attach schedule) Other assets (describe

15 16

)
Total assets (to be completed by all filers—see page 17 of

  • 29,654,540,810
  • 38,837,820,007

54,219,616
38,837,820,007

the instructions. Also, see page 1, item I)

2,025,262
0

Accounts payable and accrued expenses

...
...
...
...
...
...
...
...
...
...
17 18 19 20 21 22

4,423,063,100

  • Grants payable .
  • .

.
..
..
..
..
..
..
..

Deferred revenue Loans from officers, directors, trustees, and other disqualified persons Mortgages and other notes payable (attach schedule) Other liabilities (describe

  • .
  • .
  • .
  • .
  • .

.
..

)

  • 2,025,262
  • 4,477,282,716

34,360,537,291

  • 23
  • Total liabilities (add lines 17 through 22)

Foundations that follow SFAS 117, check here and complete lines 24 through 26 and lines 30 and 31.

  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .

29,652,515,548

Unrestricted .

Temporarily restricted Permanently restricted

  • .
  • .
  • .
  • .

..
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
24 25 26
Foundations that do not follow SFAS 117, check here and complete lines 27 through 31.

Capital stock, trust principal, or current funds

Recommended publications
  • Developing Vaccines for Neglected Diseases

    Developing Vaccines for Neglected Diseases

    Developing Vaccines for Neglected Diseases Vaccine Technologies II Albufeira, Portugal June 5th, 2008 Douglas Holtzman, Ph.D., M.P.H. Senior Program Officer, Global Health Program Bill & Melinda Gates Foundation 1 Three Programs, One Goal: Equity US Program » High school education » Public library internet access Global Development » Financial services for the poor (e.g. microfinance) » Agricultural productivity and markets Global Health 2 Perspective on Global Health The vision: To ensure that a child born in the developing world has the same chance for good health as a child born in the developed world The goal: Build on advances in science and technology to save lives, improve health, and reduce disease in the developing world 3 Prioritization Burden of disease Inequity of burden Lack of attention Possibility for impact 4 Disease Areas HIV (vaccines, microbicides, treatment, prevention, education) TB (drugs, vaccines, diagnostics) Malaria (drugs, vaccines, vector control, diagnostics, scale-up) Pneumonia Diarrhea Nutrition Maternal Health Discover, develop and deliver Kinetoplastids innovative solutions Helminths HPV Dengue/Japanese Encephalitis Polio 5 Partnerships Global Alliance for Vaccines and Immunization (GAVI) Global Fund for AIDS, TB and Malaria HIV Vaccine Enterprise Medicines for Malaria Venture (MMV) Malaria Vaccine Initiative (MVI) MACEPA PATH Vaccine Solutions (PVS) Aeras (TB Vaccines) Global Alliance for TB Drug Development (GATB) ACHAP Grand Challenges in Global Health IVI/PDVI Etc….
  • The Face of AIDS – 25 Years Later Kathi's Story, P.6-7 Inside This Issue Letter from the Executive Director

    The Face of AIDS – 25 Years Later Kathi's Story, P.6-7 Inside This Issue Letter from the Executive Director

    THE NOV '10- JAN '11 Vol. 21 • No. 4 www.ocasf.org VOICEa publication of AIDS Services Foundation Orange County The Face of AIDS – 25 Years Later Kathi's Story, p.6-7 Inside this issue Letter from the Executive Director FEATURES Ride for a Reason – Orange County Ride for AIDS ................ 5 The Face of AIDS: 25 Years Later ..................................................... 6-7 BOARD OF DIRECTORS The Red Ball1985: Officers Advisory Board A Night of Celebration and Remembrance ............................ 8-9 Maria Marquez, M.F.T. The Honorable President The Dorothy’s: Another Hauntingly Good Time ............ 12-13 Marilyn C. Brewer, Chair Barbara Venezia State Assembly, Vice President Retired DEPARTMENTS Mark Guillod, C.P.A. Tammie J. Arnold Letter from the Executive Director .................................................... 3 Treasurer Managing Director, PIMCO Mark Gonzales Around ASF ..................................................................................................... 4 Secretary Barbara Boxer U.S. Senator HIV in the News .......................................................................................... 10 Members Dean Corey Patron's Council .......................................................................................... 11 Executive Director, Brian Bates, C.P.A. O.C. Philharmonic Soc. Memorials & Tributes .............................................................................. 14 David W. Bennett, Ron Davies Grants & Save the Dates .......................................................................
  • Infectious Diseases

    Infectious Diseases

    2013 MEDICINES IN DEVELOPMENT REPORT Infectious Diseases A Report on Diseases Caused by Bacteria, Viruses, Fungi and Parasites PRESENTED BY AMERICA’S BIOPHARMACEUTICAL RESEARCH COMPANIES Biopharmaceutical Research Evolves Against Infectious Diseases with Nearly 400 Medicines and Vaccines in Testing Throughout history, infectious diseases hepatitis C that inhibits the enzyme have taken a devastating toll on the lives essential for viral replication. and well-being of people around the • An anti-malarial drug that has shown Medicines in Development world. Caused when pathogens such activity against Plasmodium falci- For Infectious Diseases as bacteria or viruses enter a body and parum malaria which is resistant to multiply, infectious diseases were the current treatments. Application leading cause of death in the United Submitted States until the 1920s. Today, vaccines • A potential new antibiotic to treat methicillin-resistant Staphylococcus Phase III and infectious disease treatments have proven to be effective treatments in aureus (MRSA). Phase II many cases, but infectious diseases still • A novel treatment that works by Phase I pose a very serious threat to patients. blocking the ability of the smallpox Recently, some infectious pathogens, virus to spread to other cells, thus 226 such as pseudomonas bacteria, have preventing it from causing disease. become resistant to available treatments. Infectious diseases may never be fully Diseases once considered conquered, eradicated. However, new knowledge, such as tuberculosis, have reemerged new technologies, and the continuing as a growing health threat. commitment of America’s biopharma- America’s biopharmaceutical research ceutical research companies can help companies are developing 394 medicines meet the continuing—and ever-changing and vaccines to combat the many threats —threat from infectious diseases.
  • TIME Global Health Summit Supported by the Bill & Melinda Gates Foundation Nov. 1

    TIME Global Health Summit Supported by the Bill & Melinda Gates Foundation Nov. 1

    TIME MAGAZINE TO CONVENE LEADERS TO DEVELOP SOLUTIONS TO GLOBAL HEALTH CHALLENGES Speakers Include Bill Gates, Richard Branson, Lee Jong-wook, Ted Turner, Ann Veneman, Paul Farmer, Madeleine Albright, Paul Wolfowitz, Agnes Binagwaho, Rick Warren, Julie Gerberding and Bono TIME Global Health Summit Supported by the Bill & Melinda Gates Foundation Nov. 1– 3, 2005, in New York City New York, NY (October 4, 2005) – TIME magazine will focus Americaʼs attention on global health during the TIME Global Health Summit, November 1-3, 2005, in New York City. Supported by the Bill & Melinda Gates Foundation, the TIME Summit will convene leaders in medicine, government, business, public policy and the arts to develop actions and solutions to health crises. TIME is partnering with PBS, as well as ABC News, to reach a broad audience. On Monday, October 31, a TIME special issue on global health will hit newsstands, reaching more than 27 million readers around the world. On Nov. 1-3 from 9-11 pm (check local listings), PBS will premiere Rx for Survival − A Global Health Challenge™, a six-part documentary series narrated by Brad Pitt. The series is co-produced by the WGBH/NOVA Science Unit and Vulcan Productions. Also this fall, ABC News will provide expanded coverage of global health issues. The TIME Summit will be on-the-record and open to credentialed media for news coverage. “The developed nations of the world can no longer ignore the health crisis faced by millions of people every day,” said Jim Kelly, managing editor of TIME magazine. “And the challenges presented by Hurricane Katrina bring home these daunting struggles.
  • Iindoor and Outdoor Biting Behaviour of Malaria Vectors and the Potential Risk Factors That Enhance Malaria in Southern Malawi

    Iindoor and Outdoor Biting Behaviour of Malaria Vectors and the Potential Risk Factors That Enhance Malaria in Southern Malawi

    Biting behaviour of malaria vectors in southern Malawi in southern malaria vectors of behaviour Biting Indoor and outdoor biting behaviour of malaria vectors and the potential risk factors that enhance malaria in southern Malawi Monicah M. Mburu Monicah Monicah M. Mburu 2019 IIndoor and outdoor biting behaviour of malaria vectors and the potential risk factors that enhance malaria in southern Malawi Monicah M. Mburu Thesis committee Promotor Prof. Dr W. Takken Personal chair at the Laboratory of Entomology Wageningen University & Research Co-promotor Dr R.S. McCann Researcher, Laboratory of Entomology Wageningen University & Research Other members Prof. Dr J.E. Kammenga, Wageningen University & Research Prof. Dr R.W. Sauerwein, Radboud University, Nijmegen Dr M.M. van den Berg, Wageningen University & Research Dr F.T. Muijres, Wageningen University & Research This research was conducted under the auspices of the C.T. de Wit Graduate School for Production Ecology and Resource Conservation Indoor and outdoor biting behaviour of malaria vectors and the potential risk factors that enhance malaria in southern Malawi Monicah M. Mburu Thesis submitted in fulfillment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus, Prof. Dr A.P.J. Mol, in the presence of the Thesis Committee appointed by the Academic Board to be defended in public on Tuesday 23 April 2019 at 4 p.m. in the Aula. Monicah M. Mburu Indoor and outdoor biting behaviour of malaria vectors and the potential risk factors that enhance malaria in southern Malawi 198 pages PhD thesis, Wageningen University, Wageningen, the Netherlands (2019) With references, with summary in English ISBN 978-94-6343-430-0 DOI https://doi.org/10.18174/471415 Table of Contents Chapter 1 General introduction 7 Chapter 2 Indoor and outdoor biting behaviour of the human malaria vectors Anopheles gambiae s.s., An.
  • Recipient: Hon'ble Prime Minister of India, Hon'ble Chief Minister of Maharashtra, HE President of India, Hon'ble Chief Justice

    Recipient: Hon'ble Prime Minister of India, Hon'ble Chief Minister of Maharashtra, HE President of India, Hon'ble Chief Justice

    Recipient: Hon'ble Prime Minister of India, Hon'ble Chief Minister of Maharashtra, HE President of India, Hon'ble Chief Justice, Supreme Court of India, HE Vice President of India, Cabinet Secretary to Govt. of India, Secretary to MoEF, Election Commission of India, Deputy Secretary, Animal Welfare, Additional Principal Chief Conservator Forests, Principal Chief Conservator of Forests (Wildlife), Inspector General, Wildlife, Animal Welfare Board of India, Dr. Patangrao Shripatrao Kadam, Minister, Chief Secretary, Maharashtra, Principal Secretary, Forest, Resident Commissioner, Maharashtra, Director General of Police, Maharashtra, CCF (T), Kolhapur, Project Elephant, MoEF, and Kolhapur Police Letter: Greetings, Free Sunder: Take immediate custody: PETA India have sufficient evidences of Sunder, baby elephant is being abused by its custodians including Vinay Kore, MLA. Bombay High Court passed orders, to shift abused elephant to rescue center but concerned Authorities failed to perform their duties. OIPA - Indian People for Animals issued NOTICE under section 55 of the Wildlife Protection Act, 1972 to take immediate custody of animal, for prompt shifting after booking Vinay Kore, MLA along with all offenders, complaint lodged with Delhi Police by Naresh Kadian and Celina Jaitley with Mumbai Police for FIR against all offenders. NOTICE under section 55 of the Wildlife Protection Act, 1972 before the Chief Wildlife Warden of Maharashtra: Sunder’s shocking beatings have been caught on videotape, and veterinarians and elephant experts who examined him found him scarred, wounded and chained so tightly that he couldn’t lie down. The Jyotiba temple came into possession of Sunder in 2007, but after constant chaining and beatings came to light, Maharashtra Minister of Forests Dr Patangrao Kadam and the Project Elephant division of the Ministry of Environment and Forests issued orders for Sunder’s release to a sanctuary on 21 August 2012 and 9 November 2012, respectively.
  • 2015 Annual Report

    2015 Annual Report

    ANNUAL REPORT 2014-2015 Mission The UPMC Center for Health Security works to protect people’s health from the consequences of epidemics and disasters and to ensure that communities are resilient to major challenges. Table of Contents Letter from the Director 1 Our Work Strengthening Global Health Security 3 Improving Response to Epidemics & Biothreats 15 Raising Awareness, Building Readiness 29 Building & Strengthening the Professional Community 37 Center Leadership and Staff 45 UPMC Advances Global Health Security 56 Letter From The Director A Year of Health Security Challenges at Home and Abroad Dear Friends, The West African Ebola outbreak made painfully clear to all of us global health security, improving response to epidemics and biothreats, the importance of public health preparedness and response to serious raising awareness, and providing the professional community with infectious disease threats. It also reminded us how the health security of new knowledge, analysis, and guidance that has helped preparedness, the global community is dependent on the ability of individual countries response, and recovery. to cope with these challenges, including countries with poor public In the fall we led a Congressional seminar on the Ebola outbreak, health and medical infrastructure. Too often these important systems bringing together key staffers with leaders from CDC, USAID, and struggle with low resources and a lack of adequate support. Even in DoD who were managing the response and helped serve as a resource the US, where we have a relative abundance of resources, our public to Congressional offices over the course of the outbreak. We published health infrastructure is underfunded and vulnerable to major shocks.
  • Twitter: a Uses and Gratifications Approach

    Twitter: a Uses and Gratifications Approach

    University of Kentucky UKnowledge University of Kentucky Master's Theses Graduate School 2011 “WHAT’S HAPPENING” @TWITTER: A USES AND GRATIFICATIONS APPROACH Corey Leigh Ballard University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Ballard, Corey Leigh, "“WHAT’S HAPPENING” @TWITTER: A USES AND GRATIFICATIONS APPROACH" (2011). University of Kentucky Master's Theses. 155. https://uknowledge.uky.edu/gradschool_theses/155 This Thesis is brought to you for free and open access by the Graduate School at UKnowledge. It has been accepted for inclusion in University of Kentucky Master's Theses by an authorized administrator of UKnowledge. For more information, please contact [email protected]. ABSTRACT OF THESIS “WHAT’S HAPPENING” @TWITTER: A USES AND GRATIFICATIONS APPROACH The uses and gratifications approach places power in the hands of the audience and is a helpful perspective when trying to understand media usage, exposure, and effects. However, while the uses and gratifications approach has been applied regularly to traditional media, research explaining why people use new social media networks as well as the gratifications they obtain from them is scarce at best. This thesis provides a comprehensive overview of the uses and gratifications approach as well as the current literature about social media networks. An argument is built within the thesis to study Twitter as one social media network through the uses and gratifications theoretical lens. Research questions are provided and a survey of 216 college undergraduates was conducted. Results show that people use a variety of Twitter functions, that the gratifications sought from Twitter are not the gratifications obtained from Twitter, and that people are careful about the types of information they share on the social media network.
  • View Annual Report

    View Annual Report

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission file number 001-35023 iBio, Inc. (Exact name of registrant as specified in its charter) Delaware 26-2797813 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 9 Innovation Way, Suite 100, Newark, DE 19711 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (302) 355-0650 Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of exchange on which registered Common Stock, $0.001 par value NYSE MKT Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ¨ No x Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No x Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
  • 2014 Annual Report

    2014 Annual Report

    TREATMENT ALONE IS NOT ENOUGH KEEP A CHILD ALIVE | ANNUAL REPORT 2014 CARE, You may have noticed that in 2014 we changed our For example, when we first started working with Alive logo and added this tag line: Committed to the End of Medical Services in Kampala, Uganda, the organization AIDS. Why? Because interest and investment in the was serving six people in the back of a church. Today, it COMMUNITY AIDS response are waning and we are calling on provides HIV treatment and care to more than 12,000 ourselves, our community, and the general public to people, while also offering innovative programs to & ONE HELL OF recommit to ending the AIDS epidemic—no barriers to address the underlying social and economic issues that treatment, no new infections, no discrimination. fuel the epidemic. Economic empowerment initiatives A COMMITMENT The end. provide women with skills and a means to earn money We know what to do; we just need to stay the course. to support their families. Women are also schooled in organic, sustainable gardening, providing a source of From day one, Keep a Child Alive (KCA) has believed healthy food as well as income. And a focus on and and invested in a community-based approach to investment in young people living with HIV has created fighting this epidemic. And in 2014, with the dramatic a movement of young activists—leaders in their unfolding of events in Ferguson, Missouri, the birth of communities—who are creating the change they want the Black Lives Matter movement, and the Ebola to see in the fight against AIDS.
  • Antigen Discovery in Trypanosoma Vivax

    Antigen Discovery in Trypanosoma Vivax

    Antigen discovery in Trypanosoma vivax Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor in Philosophy by Alessandra Isabella Romero Ramirez February 2020 Author’s declaration The expression of recombinant proteins was performed by Dr. Nicole Muller-Sienerth at the Cell Surface Signalling Laboratory from the Wellcome Trust Sanger Institute (Cambridge, UK). The mice immunization and challenge was carried out by Dr. Delphine Autheman from the Cell Surface Signalling Laboratory at the animal facility from the Wellcome Trust Sanger Institute. The immunization and challenge of goats as well as sample collection was performed by MSc. Kayo José Garcia de Almeida Castilho Neto at the Faculty of Agricultural and Veterinary Sciences from the Sao Paulo State University (UNESP) in Jaboticabal, Sao Paulo, Brazil. Except from the advice acknowledged, I declare that this thesis is a presentation of my own original work. Alessandra Isabella Romero Ramirez 20th February 2020 I ACKNOWLEDGEMENTS First of all, I would like to express my sincere gratitude to my PhD thesis supervisor, Dr. Andrew Jackson for his guidance throughout the project, patience and belief in me. I highly appreciate his motivation, immense knowledge and critical advice during these years. I am truly thankful for the guidance and opportunities given. I gratefully acknowledge the funding body that made my PhD work possible. I was funded by FONDECYT-CONCYTEC, the National Council of Science, Technology and Innovation from Peru (grant contract number 001-2016-FONDECYT). I would specially like to acknowledge members from the Cell Surface Signalling laboratory at the Wellcome Sanger Institute, to the group leader Gavin Wright, postdoctoral Delphine Autheman and the senior technician Nicole Muller-Sienerth for their enormous contribution on this doctoral project.
  • King County King County Was Organized in 1852 from Lewis County

    King County King County Was Organized in 1852 from Lewis County

    King County King County was organized in 1852 from Lewis County. It was originally named after William R. King, Vice President under Franklin Pierce; it was renamed, in 1986, after civil rights leader Martin Luther King. The first settlements in the county were the donation land claims of Luther Collins, Henry Van Asselt, and Jacob Maple in September of 1851 in the Duwamish Valley area of present day Seattle. This settlement was followed in November by one led by David Denny and Leander Terry at Alki Pont. The next year the Denny-Terry settlers moved to a better location for loading lumber on the east side of Elliott Bay and named the settlement Seattle after the friendly chief of the Duwamish Indians. The next year Henry Yesler set up the first steam sawmill on Puget Sound. King County and Seattle grew and prospered during the late nineteenth and early twentieth centuries with the expansion of the shipping and lumber industries. It boomed again during and after World War II as an aircraft production and shipbuilding center. Today the county is the Pacific Northwest region’s major manufacturing and shipping center. Bounded by: Snohomish County (N), Chelan and Kittitas counties (E), Pierce County (S), and Puget Sound and Kitsap County (W). County Seat: Seattle Chambers of Commerce: Auburn Area Chamber of Commerce, 108 S Division #B, Auburn, WA, 98001-5305. Website: http://www.auburnareawa.org/ Phone 253-833-0700. Fax 253-735-4091. Ballard-Seattle Chamber of Commerce, 2208 NW Market St. #100, Ballard, WA 98107- 4030. Website www.ballardchamber.com Phone 206-784-9705, Fax 206-783-8154.